About Dr. Li Huabin
Dr. Li Huabin (李华斌) is the Director of the Department of Otolaryngology – Head & Neck Surgery at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine — one of China's most prestigious academic medical centers. A nationally recognized authority in rhinology and allergic airway disease, Dr. Li is one of China's foremost experts in allergic rhinitis, chronic rhinosinusitis, and the unified airway concept linking upper and lower respiratory tract inflammation. His research and clinical work have shaped national guidelines for allergic rhinitis management and have positioned Ruijin Hospital as a leading center for allergic airway disease in China.
Dr. Li leads a comprehensive ENT department that integrates advanced endoscopic surgical capabilities with a strong allergy and immunology program, enabling a truly multidisciplinary approach to sinonasal and airway diseases. He is known for his evidence-based approach to treatment, his expertise in allergen immunotherapy, and his ability to manage complex patients with overlapping rhinitis, asthma, and chronic sinusitis — a patient population that is increasingly prevalent and often inadequately managed in fragmented healthcare systems.
Hospital Affiliation
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine is consistently ranked among China's top five hospitals and is one of Shanghai's most respected academic medical centers. Its Department of Otolaryngology benefits from close collaboration with the hospital's allergy, pulmonology, immunology, and oncology departments, enabling comprehensive multidisciplinary management of allergic airway disease, sinonasal tumors, and head & neck cancers.
The department is equipped with state-of-the-art endoscopic imaging systems, comprehensive allergy testing facilities including skin prick testing and specific IgE measurement, intraoperative navigation for complex sinus and skull base surgery, and advanced audiological testing. Ruijin's strong research infrastructure supports ongoing clinical trials in allergic rhinitis, biologic therapy for CRS, and head & neck oncology.
Clinical Expertise
- Allergic rhinitis — comprehensive allergy evaluation; subcutaneous and sublingual allergen immunotherapy (SCIT/SLIT); pharmacological management; unified airway approach with asthma co-management
- Chronic rhinosinusitis & nasal polyps — FESS; revision sinus surgery; biologic therapy (dupilumab, mepolizumab) for refractory eosinophilic CRS; image-guided surgery
- Allergic asthma & united airway disease — multidisciplinary rhinitis-asthma co-management; biologic therapy coordination with pulmonology; anti-IgE therapy (omalizumab)
- Sinonasal tumors — inverted papilloma; sinonasal malignancies; endoscopic and open resection; anterior skull base involvement
- Head & neck cancer — laryngeal, hypopharyngeal, and oral cavity cancers; thyroid cancer; multidisciplinary oncological management with radiation and medical oncology
- Thyroid & parathyroid surgery — thyroidectomy; minimally invasive endoscopic thyroid surgery; parathyroidectomy; intraoperative nerve monitoring
- Otitis media & chronic ear disease — tympanoplasty; mastoidectomy; cholesteatoma surgery; ossicular chain reconstruction
- Smell & taste disorders — post-viral anosmia; post-COVID smell loss; olfactory training; sinonasal cause evaluation
- Voice & swallowing disorders — laryngoscopic evaluation; vocal cord lesions; laryngeal microsurgery; dysphagia assessment
- Obstructive sleep apnea — polysomnography coordination; surgical management; CPAP optimization
- Pediatric ENT — adenotonsillectomy; pediatric allergic rhinitis; otitis media with effusion; pediatric airway management
Academic & Research Contributions
Dr. Li Huabin is one of China's most influential rhinology and allergy researchers, with hundreds of peer-reviewed publications in leading journals including the Journal of Allergy and Clinical Immunology, Allergy, International Forum of Allergy & Rhinology, and the European Archives of Oto-Rhino-Laryngology. His research focuses on the epidemiology and pathogenesis of allergic rhinitis in Chinese populations, the efficacy of allergen immunotherapy in Asian patients, the unified airway concept, and the optimization of biologic therapies for eosinophilic airway disease.
He has served as Chair of the Rhinology and Allergy Group of the Chinese Society of Otorhinolaryngology – Head & Neck Surgery and has been the principal author and contributor to China's national clinical guidelines for allergic rhinitis — guidelines that are now the standard reference for ENT specialists and allergists across the country. Dr. Li has served as principal investigator on multiple NSFC-funded research programs and multicenter clinical trials evaluating allergen immunotherapy and biologic therapies in Chinese patients.
Internationally, Dr. Li is a recognized contributor to the ARIA (Allergic Rhinitis and its Impact on Asthma) guidelines group and has collaborated with leading allergy and rhinology centers in Europe and North America. He is a regular presenter at the European Academy of Allergy and Clinical Immunology (EAACI) Congress, the American Academy of Otolaryngology – Head & Neck Surgery (AAO-HNS) annual meeting, and the International Rhinologic Society (IRS) Congress.
His work on the epidemiology of allergic rhinitis in China — including large-scale prevalence studies showing rapidly rising rates of allergic disease in urban Chinese populations — has been widely cited internationally and has informed public health policy on environmental allergen control and immunotherapy access in China.
Why International Patients Choose Dr. Li Huabin
International patients — including expatriates living in Shanghai who develop allergic rhinitis or sinusitis in response to China's urban environment, and visitors from abroad with refractory allergic airway disease — seek Dr. Li's expertise for comprehensive allergy evaluation, allergen immunotherapy initiation, and management of chronic rhinosinusitis that has not responded to standard treatment.
Expatriates in Shanghai frequently develop new-onset or worsening allergic rhinitis due to exposure to local tree pollens, house dust mites, and air pollution — allergen profiles that differ significantly from their home countries. Dr. Li's team offers comprehensive local allergen testing and immunotherapy programs tailored to Shanghai's specific allergen environment, providing a level of localized expertise that is genuinely difficult to replicate elsewhere.
For patients with refractory nasal polyps or eosinophilic CRS, access to biologic therapies including dupilumab at significantly lower cost than in Western markets makes Shanghai an increasingly attractive destination for long-term disease management. CMCS coordinates all aspects of the allergy and rhinology consultation, from appointment scheduling and medical record translation to immunotherapy coordination and remote follow-up support.
What to Expect at Your Consultation
Consultations with Dr. Li begin with a comprehensive allergic and rhinological history, nasal endoscopy, and review of prior allergy testing, imaging, and treatment records. CMCS will arrange certified translation of all medical records in advance. Where additional diagnostics — including skin prick testing, specific IgE panel, CT sinuses, or pulmonary function testing — are needed, these can typically be arranged within 24–48 hours. Dr. Li will provide a detailed management plan including allergen avoidance strategies, pharmacotherapy optimization, immunotherapy protocols, and surgical planning where indicated — all summarized in English for your home allergist or ENT surgeon.
Frequently Asked Questions
I developed severe allergic rhinitis after moving to Shanghai. Can Dr. Li help?
Yes. This is one of the most common presentations in Dr. Li's international patient practice. His team will perform comprehensive local allergen testing and design an individualized management plan including allergen avoidance, pharmacotherapy, and immunotherapy if appropriate.
Is sublingual immunotherapy (SLIT) available at Ruijin?
Yes. Both subcutaneous (SCIT) and sublingual (SLIT) allergen immunotherapy are available, including house dust mite SLIT drops that can be continued at home after initiation in Shanghai.
Can Dr. Li manage both my allergic rhinitis and asthma together?
Yes. Dr. Li's unified airway approach integrates rhinitis and asthma management, with close collaboration with Ruijin's pulmonology department for patients with concurrent lower airway disease. Biologic therapies targeting both conditions — such as dupilumab and omalizumab — are available at Ruijin.
Book a Consultation Through CMCS
China Medical Concierge Shanghai (CMCS) provides end-to-end support for international patients seeking ENT and allergy care with Dr. Li Huabin at Ruijin Hospital, including priority appointment scheduling, certified medical translation, allergy testing coordination, and post-consultation follow-up. Contact us at contract@medicalsh.com, or visit medicalsh.com.
0 comentarios